ArticleShoulder & elbow2026
Volume-outcome relationships for primary total elbow arthroplasty surgery in England: Analysis of the hospital episode statistics dataset.
Article in Shoulder & elbow, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Total elbow arthroplasty (TEA) is a low-volume, high-complexity procedure and clinical guidelines recommend moving to a centralised network model. The aim of the study was to assess the effect of surgeon and unit volume on patient and service level clinical outcomes. Methods: Analysis the Hospital Episodes Statistics database (HES) for elective and emergency primary TEA surgery between January 2014 and December 2023 was performed. The exposures of interest were surgeon and trust volume in the 12 months preceding index surgery. The primary outcome was revision surgery within 12 months of index procedure. Secondary outcomes were 30-day emergency readmission and length of stay (LOS) greater than the median. Results: In total, 4101 primary TEA cases performed in 123 trusts were included. One-year revision and 30-day emergency readmission were not associated with trust or surgeon volume. LOS greater than the median showed a significant association with both surgeon and unit TEA volume. Patients undergoing primary TEA by surgeons performing fewer than 10 cases per year have three times the likelihood of LOS over three days. Conclusion: There are significant resource savings from networked service reconfiguration. Careful monitoring of clinical outcomes is required, ideally using patient reported outcomes in addition to implant survival, readmission and LOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.